| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 300,471 | 306,126 | 277,433 | 265,295 | | Cost of Revenue |
-
|
-
|
-
| 765,012 | | | Gross Profit | 300,471 | 306,126 | 277,433 | (499,717) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 252,304 | 244,074 | 238,160 | (532,729) | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 48,167 | 62,052 | 39,273 | 33,012 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,687 | 10,472 | 4,069 | (21,993) | | Earnings Before Interest And Taxes | 51,102 | 45,725 | 15,312 | (3,581) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 51,102 | 45,725 | 15,312 | (3,581) | | Income Tax Expense | 16,440 | 14,855 | 2,623 | (685) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 39,686 | 32,734 | 11,129 | (6,302) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 39,686 | 32,734 | 11,129 | (6,302) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $39,686 | $32,734 | $11,129 | ($6,302) |
|
0.02% Nasdaq 
0.33%
Income Statement
